Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FeCOVER Z is an oral nutritional supplement developed by Ambiens Pharmaceuticals. It is a combination product containing ferrous ascorbate, folic acid (Vitamin B9), and zinc. Ferrous ascorbate provides a highly bioavailable source of iron for hemoglobin synthesis, addressing iron-deficiency anemia. Folic acid is essential for DNA synthesis and the maturation of red blood cells, while zinc acts as a vital cofactor for numerous enzymes involved in cellular metabolism, protein synthesis, and immune function. The supplement is primarily indicated for the management of nutritional deficiencies, particularly during pregnancy, lactation, and recovery from illness or chronic blood loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ferrous ascorbate + folic acid + zinc (Ambiens Pharmaceuticals).